CHEOY:OTCMKTS
Cochlear Ord ADR
44,72 US$
arrow_downward
-0,07%(-0,030) 1K
15-okt, 16:00:00 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoCHEOY tikeri uchun statistika yaratilmoqda...
Ochish
44,61 US$
Yuqori
44,82 US$
Past
44,60 US$
Bozor kapitali
8,58 mlrd
Oʻrtacha hajm
18,50 ming
Hajmi
26,66 ming
52 haftalik eng yuqori
98,49 US$
52 haftalik eng past
31,82 US$
Beta
0,68
Muomaladagi aksiyalar
130,80 mln
Xodimlar soni
5 ming
Ochish
44,61 US$
Yuqori
44,82 US$
Past
44,60 US$
Bozor kapitali
8,58 mlrd
Oʻrtacha hajm
18,50 ming
Hajmi
26,66 ming
52 haftalik eng yuqori
98,49 US$
52 haftalik eng past
31,82 US$
Beta
0,68
Muomaladagi aksiyalar
130,80 mln
Xodimlar soni
5 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Simply Wall Street
·
15 soat oldin
Cochlear And 2 Australian Healthcare Stocks To Watch
PR Newswire
·
1 kun oldin
Cochlear Named #1 Most Trustworthy Healthcare Company In The World For 2026
Profil
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.
Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015.
Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. Wikipedia
Cochlear Ord ADR haqida
CEODig Howitt
Xodimlar soni5,4 ming
Asos solingan1981
Bosh ofislarSidney, Yangi janubiy uels, Avstraliya
Sektor-
Veb-saytcochlear.com